As of 2025-06-14, the EV/EBITDA ratio of Pharmaniaga Bhd (PHARMA.KL) is 5.07. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PHARMA.KL's latest enterprise value is 1,368.97 mil MYR. PHARMA.KL's TTM EBITDA according to its financial statements is 270.09 mil MYR. Dividing these 2 quantities gives us the above PHARMA.KL EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 4.8x - 5.5x | 5.2x |
| Forward P/E multiples | 4.6x - 5.7x | 5.1x |
| Fair Price | 0.19 - 0.48 | 0.31 |
| Upside | -22.1% - 95.2% | 24.5% |
| Date | EV/EBITDA |
| 2025-06-13 | 5.07 |
| 2025-06-12 | 5.07 |
| 2025-06-11 | 5.10 |
| 2025-06-10 | 5.18 |
| 2025-06-09 | 5.20 |
| 2025-06-06 | 5.12 |
| 2025-06-05 | 5.12 |
| 2025-06-04 | 5.07 |
| 2025-06-03 | 5.10 |
| 2025-05-30 | 5.07 |
| 2025-05-29 | 5.10 |
| 2025-05-28 | 5.07 |
| 2025-05-27 | 5.10 |
| 2025-05-26 | 5.10 |
| 2025-05-23 | 5.18 |
| 2025-05-22 | 5.26 |
| 2025-05-21 | 5.26 |
| 2025-05-20 | 5.31 |
| 2025-05-19 | 5.31 |
| 2025-05-16 | 5.34 |
| 2025-05-15 | 5.28 |
| 2025-05-14 | 5.31 |
| 2025-05-13 | 5.34 |
| 2025-05-09 | 5.39 |
| 2025-05-08 | 5.36 |
| 2025-05-07 | 5.12 |
| 2025-05-06 | 5.10 |
| 2025-05-05 | 5.10 |
| 2025-05-02 | 5.15 |
| 2025-04-30 | 5.10 |
| 2025-04-29 | 5.18 |
| 2025-04-28 | 5.20 |
| 2025-04-25 | 5.18 |
| 2025-04-24 | 5.07 |
| 2025-04-23 | 5.07 |
| 2025-04-22 | 5.02 |
| 2025-04-21 | 5.04 |
| 2025-04-18 | 5.04 |
| 2025-04-17 | 5.02 |
| 2025-04-16 | 5.04 |
| 2025-04-15 | 5.04 |
| 2025-04-14 | 4.94 |
| 2025-04-11 | 4.94 |
| 2025-04-10 | 4.94 |
| 2025-04-09 | 4.86 |
| 2025-04-08 | 4.91 |
| 2025-04-07 | 4.86 |
| 2025-04-04 | 4.99 |
| 2025-04-03 | 5.02 |
| 2025-04-02 | 5.04 |